The purpose of this study is to evaluate the safety, efficacy, and tolerability of Chantix versus a placebo in adolescent smokers who are motivated to quit smoking.

Duration:  Up to 1 year

Number of visits to CKRA:  At least 23

Compensation:  Up to $805 for completion

NOTE:  Qualifed participants must be between the ages of 12 and 19 years old and be in general good health.  Other criteria also apply.